Citations (118)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yongqiang Chen, Elizabeth S. Henson, Wenyan Xiao, Daniel Huang, Eileen M. McMillan-Ward, Sara J. Israels & Spencer B. Gibson. (2016) Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia. Autophagy 12:6, pages 1029-1046.
Read now
Read now
Articles from other publishers (117)
Roni Touboul, Stavroula Baritaki, Apostolos Zaravinos & Benjamin Bonavida. (2021) RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity. Cancers 13:24, pages 6247.
Crossref
Crossref
Hajrah Khawaja, Andrew Campbell, Jamie Z. Roberts, Arman Javadi, Paul O’Reilly, Darragh McArt, Wendy L. Allen, Joanna Majkut, Markus Rehm, Alberto Bardelli, Federica Di Nicolantonio, Christopher J. Scott, Richard Kennedy, Nicolas Vitale, Timothy Harrison, Owen J. Sansom, Daniel B. Longley, Emma Evergren & Sandra Van Schaeybroeck. (2020) RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer. Cell Death & Disease 11:10.
Crossref
Crossref
Gerardo D. Anaya-Eugenio, Daniela Rebollar-Ramos, Maria del Carmen González, Huzefa Raja, Rachel Mata & Esperanza J. Carcache de Blanco. (2019) Apoptotic activity of xanthoquinodin JBIR-99, from Parengyodontium album MEXU 30054, in PC-3 human prostate cancer cells. Chemico-Biological Interactions 311, pages 108798.
Crossref
Crossref
Mohammed I. Y. Elmallah & Olivier Micheau. (2019) Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy. Cancers 11:6, pages 850.
Crossref
Crossref
Sara Ibrahim, Rania Dayoub, Sabrina Krautbauer, Gerhard Liebisch, Anja Kathrin Wege, Michael Melter & Thomas S. Weiss. (2019) Bile acid-induced apoptosis and bile acid synthesis are reduced by over-expression of Augmenter of Liver Regeneration (ALR) in a STAT3-dependent mechanism. Experimental Cell Research 374:1, pages 189-197.
Crossref
Crossref
Katarzyna Szołtysek, Patryk Janus, Gracjana Zając, Tomasz Stokowy, Anna Walaszczyk, Wiesława Widłak, Bartosz Wojtaś, Bartłomiej Gielniewski, Simon Cockell, Neil D. Perkins, Marek Kimmel & Piotr Widlak. (2018) RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation. BMC Genomics 19:1.
Crossref
Crossref
So Young Kim, MiNa Hong, Seung‐Ho Heo, Sojung Park, Taeg Kyu Kwon, Young Hoon Sung, Yumin Oh, Seulki Lee, Gwan‐Su Yi & Inki Kim. (2018) Inhibition of euchromatin histone‐lysine N‐methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor‐related apoptosis‐inducing ligand through reactive oxygen species‐mediated activating transcription factor 4‐C/EBP homologous protein‐death receptor 5 pathway activation. Molecular Carcinogenesis 57:11, pages 1492-1506.
Crossref
Crossref
Apostolos Zaravinos, Benjamin Bonavida, Ekaterini Chatzaki & Stavroula Baritaki. (2018) RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact. Cancers 10:9, pages 287.
Crossref
Crossref
Yitong Yang, Xuan Wang, Yueyue Zhang & Weijie Yuan. (2018) Hepatitis B virus X protein and proinflammatory cytokines synergize to enhance TRAIL-induced apoptosis of renal tubular cells by upregulation of DR4. The International Journal of Biochemistry & Cell Biology 97, pages 62-72.
Crossref
Crossref
Deepak Bhere, Kaoru Tamura, Hiroaki Wakimoto, Sung Hugh Choi, Benjamin Purow, Jeremy Debatisse & Khalid Shah. (2018) microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis. Neuro-Oncology 20:2, pages 215-224.
Crossref
Crossref
Chin-Yi Cheng & Jaung-Geng Lin. 2018. Experimental Acupuncturology. Experimental Acupuncturology
95
117
.
Anna Shvartsur, Kevin B. Givechian, Hermes Garban & Benjamin Bonavida. (2017) Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Alessandra Zingoni, Cinzia Fionda, Cristiana Borrelli, Marco Cippitelli, Angela Santoni & Alessandra Soriani. (2017) Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance. Frontiers in Immunology 8.
Crossref
Crossref
Sheau-Yun Yuan, Ming-Yuh Shiau, Yen-Chuan Ou, Yu-Chia Huang, Cheng-Che Chen, Chen-Li Cheng, Kun-Yuan Chiu, Shian-Shiang Wang & Kan-Jen Tsai. (2017) Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells. Oncology Reports 37:6, pages 3606-3616.
Crossref
Crossref
Pi Chu Liu, Gang Lu, Yi Deng, Cheng Dong Wang, Xian Wei Su, Jing Ye Zhou, Tat Ming Chan, Xiang Hu & Wai Sang Poon. (2017) Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy. PLOS ONE 12:1, pages e0171157.
Crossref
Crossref
Chandini Thirukkumaran, Zhong-Qiao Shi, Ponnampalam Thirukkumaran, Joanne Luider, Karen Kopciuk, Jason Spurrell, Kate Elzinga & Don Morris. (2017) PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer. PLOS ONE 12:1, pages e0168233.
Crossref
Crossref
Michael Krainer & Ahmed El-Gazzar. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets
871
880
.
Yuting Liu, Yunli Tong, Xia Yang, Fangyuan Li, Liang Zheng, Wenqin Liu, Jinjun Wu, Rilan Ou, Guiyu Zhang, Ming Hu, Zhongqiu Liu & Linlin Lu. (2016) Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer. Pharmacological Research 111, pages 113-125.
Crossref
Crossref
U Beyer, S K Krönung, A Leha, L Walter & M Dobbelstein. (2015) Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death. Cell Death & Differentiation 23:1, pages 64-75.
Crossref
Crossref
Koen MO Galenkamp, Paulina Carriba, Jorge Urresti, Laura Planells-Ferrer, Elena Coccia, Joaquín Lopez-Soriano, Bruna Barneda-Zahonero, Rana S Moubarak, Miguel F Segura & Joan X Comella. (2015) TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas. Molecular Cancer 14:1.
Crossref
Crossref
Abedul Haque, Mohammad A. Rahman, James R. Fuchs, Zhuo Georgia Chen, Fadlo R. Khuri, Dong M. Shin & A.R.M. Ruhul Amin. (2015) FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway. Cancer Letters 363:2, pages 166-175.
Crossref
Crossref
Nassir M. Mansour, Giovanna M. Bernal, Longtao Wu, Clayton D. Crawley, Kirk E. Cahill, David J. Voce, Irina V. Balyasnikova, Wei Zhang, Ruben Spretz, Luis Nunez, Gustavo F. Larsen, Ralph R. Weichselbaum & Bakhtiar Yamini. (2015) Decoy Receptor DcR1 Is Induced in a p50/Bcl3–Dependent Manner and Attenuates the Efficacy of Temozolomide. Cancer Research 75:10, pages 2039-2048.
Crossref
Crossref
Tianliang Li, Ling Su, Yuanjiu Lei, Xianfang Liu, Yajing Zhang & Xiangguo Liu. (2015) DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells. Journal of Biological Chemistry 290:17, pages 11108-11118.
Crossref
Crossref
Julianne D. Twomey, Su-Ryun Kim, Liqun Zhao, William P. Bozza & Baolin Zhang. (2015) Spatial dynamics of TRAIL death receptors in cancer cells. Drug Resistance Updates 19, pages 13-21.
Crossref
Crossref
Marzia Pennati, Stefania Sbarra, Michelandrea De Cesare, Alessia Lopergolo, Silvia L. Locatelli, Elisa Campi, Maria Grazia Daidone, Carmelo Carlo-Stella, Alessandro M. Gianni & Nadia Zaffaroni. (2015) YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation. International Journal of Cancer 136:2, pages 299-309.
Crossref
Crossref
Bo Li, Ying Gao, Gary O. Rankin, Yon Rojanasakul, Stephen J. Cutler, Youying Tu & Yi Charlie Chen. (2015) Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells. Cancer Letters 356:2, pages 418-433.
Crossref
Crossref
C R Schlegel, A-V Fonseca, S Stöcker, M L Georgiou, M B Misterek, C E Munro, C R Carmo, M J Seckl & A P Costa-Pereira. (2014) DAPK2 is a novel modulator of TRAIL-induced apoptosis. Cell Death & Differentiation 21:11, pages 1780-1791.
Crossref
Crossref
Alessio Iannetti, Adeline C. Ledoux, Susan J. Tudhope, Hélène Sellier, Bo Zhao, Sophia Mowla, Adam Moore, Holger Hummerich, Benjamin E. Gewurz, Simon J. Cockell, Parmjit S. Jat, Elaine Willmore & Neil D. Perkins. (2014) Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence. PLoS Genetics 10:9, pages e1004642.
Crossref
Crossref
Mano Horinaka, Tatsushi Yoshida, Mitsuhiro Tomosugi, Shusuke Yasuda, Yoshihiro Sowa & Toshiyuki Sakai. (2014) Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells. Scientific Reports 4:1.
Crossref
Crossref
Makoto Edagawa, Junya Kawauchi, Manabu Hirata, Hiroto Goshima, Makoto Inoue, Tatsuro Okamoto, Akira Murakami, Yoshihiko Maehara & Shigetaka Kitajima. (2014) Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib. Journal of Biological Chemistry 289:31, pages 21544-21561.
Crossref
Crossref
Thomas Condamine, Vinit Kumar, Indu R. Ramachandran, Je-In Youn, Esteban Celis, Niklas Finnberg, Wafik S. El-Deiry, Rafael Winograd, Robert H. Vonderheide, Nickolas R. English, Stella C. Knight, Hideo Yagita, Judith C. McCaffrey, Scott Antonia, Neil Hockstein, Robert Witt, Gregory Masters, Thomas Bauer & Dmitry I. Gabrilovich. (2014) ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis. Journal of Clinical Investigation 124:6, pages 2626-2639.
Crossref
Crossref
Chiara Gasparini, Claudio Celeghini, Lorenzo Monasta & Giorgio Zauli. (2014) NF-κB pathways in hematological malignancies. Cellular and Molecular Life Sciences 71:11, pages 2083-2102.
Crossref
Crossref
Arumugam Nagalingam, Panjamurthy Kuppusamy, Shivendra V. Singh, Dipali Sharma & Neeraj K. Saxena. (2014) Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer. Cancer Research 74:9, pages 2617-2629.
Crossref
Crossref
Talha Abdul Halim, Ammad Ahmad Farooqi & Farrukh Zaman. (2013) Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes. Cancer Cell International 13:1.
Crossref
Crossref
I Eckhardt, S Roesler & S Fulda. (2013) Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis. Cell Death & Disease 4:11, pages e936-e936.
Crossref
Crossref
R.G.P.T. Jayasooriya, Dong-Oh Moon, Sung Gyu Yun, Yung Hyun Choi, Yukihiro Asami, Mun-Ock Kim, Jae-Hyuk Jang, Bo Yeon Kim, Jong Seog Ahn & Gi-Young Kim. (2013) Verrucarin A enhances TRAIL-induced apoptosis via NF-κB-mediated Fas overexpression. Food and Chemical Toxicology 55, pages 1-7.
Crossref
Crossref
T R Burton, E S Henson, M B Azad, M Brown, D D Eisenstat & S B Gibson. (2013) BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas. Cell Death & Disease 4:4, pages e587-e587.
Crossref
Crossref
Archana Gopalan, Weiping Yu, Bob G. Sanders & Kimberly Kline. (2013) Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Letters 329:1, pages 9-16.
Crossref
Crossref
Hongqin Zhuang, Weiwei Jiang, Xiangyu Zhang, Fan Qiu, Ziyi Gan, Wei Cheng, Jing Zhang, Shengwen Guan, Bo Tang, Qilai Huang, Xinhua Wu, Xiaofeng Huang, Wenhui Jiang, Qingang Hu, Min Lu & Zi-Chun Hua. (2012) Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions. Journal of Molecular Medicine 91:2, pages 219-235.
Crossref
Crossref
Anita C. Bellail & Chunhai Hao. 2013. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy
213
243
.
Michael Krainer & Ahmed El-Gazzar. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets
1
10
.
Caterina Iofrida, Erika Melissari, Veronica Mariotti, Chiara Guglielmi, Lucia Guidugli, Maria Adelaide Caligo & Silvia Pellegrini. (2012) Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study. BMC Cancer 12:1.
Crossref
Crossref
Juan Li, Kai Wang, Xuedan Chen, Hui Meng, Min Song, Yan Wang, Xueqing Xu & Yun Bai. (2012) Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Molecular Biology 13:1.
Crossref
Crossref
X Zhang, T Inukai, K Hirose, K Akahane, I Kuroda, H Honna-Oshiro, K Kagami, K Goi, K Nakamura, M Kobayashi, M Endo, H Yagita, H Kurosawa, A Thomas Look, H Honda, T Inaba, S Nakazawa & K Sugita. (2012) Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors. Leukemia 26:12, pages 2483-2493.
Crossref
Crossref
Archana Gopalan, Weiping Yu, Qing Jiang, Yumi Jang, Bob G. Sanders & Kimberly Kline. (2012) Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells. Molecular Nutrition & Food Research 56:12, pages 1803-1811.
Crossref
Crossref
Su-Hoon Lee, Hak-Bng Kim, Mi-Ju Kim, Jae-Won Lee, Jae-Ho Bae, Dong-Wan Kim, Chi-Dug Kang & Sun-Hee Kim. (2012) Inhibition of SIRT1 Sensitizes TRAIL-Resistant MCF-7 Cells by Upregulation of DR5 and Inhibition of c-FLIP. Journal of Life Science 22:10, pages 1277-1285.
Crossref
Crossref
Mary Pulvino, Yue Liang, David Oleksyn, Michael DeRan, Elise Van Pelt, Joel Shapiro, Ignacio Sanz, Luojing Chen & Jiyong Zhao. (2012) Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood 120:8, pages 1668-1677.
Crossref
Crossref
Hak-Bong Kim, Mi-Ju Kim, Su-Hoon Lee, Jae-Won Lee, Jae-Ho Bae, Dong-Wan Kim, Trong Tuan Dao, Won Keun Oh, Chi-Dug Kang & Sun-Hee Kim. (2012) Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis. Biochemical Pharmacology 84:3, pages 402-410.
Crossref
Crossref
Bart Claes, Bernard Siebens & Diether Lambrechts. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Danijela Maksimovic-Ivanic, Stanislava Stosic-Grujicic, Ferdinando Nicoletti & Sanja Mijatovic. (2012) Resistance to TRAIL and how to surmount it. Immunologic Research 52:1-2, pages 157-168.
Crossref
Crossref
Jonathan J. Knowlton, Terence S. Dermody & Geoffrey H. Holm. (2012) Apoptosis Induced by Mammalian Reovirus Is Beta Interferon (IFN) Independent and Enhanced by IFN Regulatory Factor 3- and NF-κB-Dependent Expression of Noxa. Journal of Virology 86:3, pages 1650-1660.
Crossref
Crossref
Neil D. Perkins. (2012) The diverse and complex roles of NF-κB subunits in cancer. Nature Reviews Cancer 12:2, pages 121-132.
Crossref
Crossref
You-Take Oh, Ping Yue, Wei Zhou, Justin M. Balko, Esther P. Black, Taofeek K. Owonikoko, Fadlo R. Khuri & Shi-Yong Sun. (2012) Oncogenic Ras and B-Raf Proteins Positively Regulate Death Receptor 5 Expression through Co-activation of ERK and JNK Signaling. Journal of Biological Chemistry 287:1, pages 257-267.
Crossref
Crossref
Ling Su, Guangbo Liu, Xuexi Hao, Ning Zhong, Diansheng Zhong, Xiangguo Liu & Sunil Singhal. (2011) Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells. European Journal of Cancer 47:16, pages 2471-2478.
Crossref
Crossref
Luke Piggott, Nader Omidvar, Salvador Martí Pérez, Matthias Eberl & Richard WE Clarkson. (2011) Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Cancer Research 13:5.
Crossref
Crossref
James A. Bonner, Christopher D. Willey, Eddy S. Yang, Michael C. Dobelbower, Leisa L. Sanford, Sheila J. Bright, Donald J. Buchsbaum & Kevin P. Raisch. (2011) Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation. Radiotherapy and Oncology 101:1, pages 183-189.
Crossref
Crossref
H Rauert, T Stühmer, R Bargou, H Wajant & D Siegmund. (2011) TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death & Disease 2:8, pages e194-e194.
Crossref
Crossref
Thomas Unterkircher, Silvia Cristofanon, Sri Hari Krishna Vellanki, Lisa Nonnenmacher, Georg Karpel-Massler, Christian Rainer Wirtz, Klaus-Michael Debatin & Simone Fulda. (2011) Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis. Clinical Cancer Research 17:12, pages 4019-4030.
Crossref
Crossref
María Elena Maldonado, Souad Bousserouel, Francine Gossé, Annelise Lobstein & Francis Raul. (2011) Implicación de NF-κB y p53 en la expresión de receptores de muerte-TRAIL y apoptosis por procianidinas en células metastásicas humanas SW620. Biomédica 30:4, pages 577.
Crossref
Crossref
Sunil Kumar Malonia, Surajit Sinha, Pavithra Lakshminarasimhan, Kamini Singh, Archana Jalota-Badhwar, Shravanti Rampalli, Ruchika Kaul-Ghanekar & Samit Chattopadhyay. (2011) Gene regulation by SMAR1: Role in cellular homeostasis and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815:1, pages 1-12.
Crossref
Crossref
Ricardo Parrondo, Alicia de las Pozas, Teresita Reiner, Priyamvada Rai & Carlos Perez-Stable. (2010) NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells. Molecular Cancer 9:1.
Crossref
Crossref
You-Take Oh, Xiangguo Liu, Ping Yue, Sumin Kang, Jing Chen, Jack Taunton, Fadlo R. Khuri & Shi-Yong Sun. (2010) ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1. Journal of Biological Chemistry 285:53, pages 41310-41319.
Crossref
Crossref
Hong Zhu, Xiao-Wen Liu, Wan-Jing Ding, Dan-Qing Xu, Yu-Chen Zhao, Wei Lu, Qiao-Jun He & Bo Yang. (2010) Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. Cancer Letters 297:2, pages 155-164.
Crossref
Crossref
Weiping Yu, Richa Tiwary, Jing Li, Sook-Kyung Park, Li Jia, Ailian Xiong, Marla Simmons-Menchaca, Bob G. Sanders & Kimberly Kline. (2010) α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Molecular Carcinogenesis 49:11, pages 964-973.
Crossref
Crossref
C Matteucci, A Minutolo, E Balestrieri, F Marino-Merlo, P Bramanti, E Garaci, B Macchi & A Mastino. (2010) Inhibition of NF-κB activation sensitizes U937 cells to 3′-azido-3′-deoxythymidine induced apoptosis. Cell Death & Disease 1:10, pages e81-e81.
Crossref
Crossref
Koshi Akahane, Takeshi Inukai, Xiaochun Zhang, Kinuko Hirose, Itaru Kuroda, Kumiko Goi, Hiroko Honna, Keiko Kagami, Shinpei Nakazawa, Kazushi Endo, Takeo Kubota, Hideo Yagita, Toshiko Koyama-Okazaki & Kanji Sugita. (2010) Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor−related apoptosis-inducing ligand-mediated apoptosis. Experimental Hematology 38:10, pages 885-895.
Crossref
Crossref
Ramaswamy Kannappan, Jayaraj Ravindran, Sahdeo Prasad, Bokyung Sung, Vivek R. Yadav, Simone Reuter, Madan M. Chaturvedi & Bharat B. Aggarwal. (2010) γ-Tocotrienol Promotes TRAIL-Induced Apoptosis through Reactive Oxygen Species/Extracellular Signal-Regulated Kinase/p53–Mediated Upregulation of Death Receptors. Molecular Cancer Therapeutics 9:8, pages 2196-2207.
Crossref
Crossref
Manuela Frese-Schaper, Julian A. Schardt, Toshiyuki Sakai, Giovanni L. Carboni, Ralph A. Schmid & Steffen Frese. (2010) Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5. FEBS Letters 584:13, pages 2867-2871.
Crossref
Crossref
B Claes, I Buysschaert & D Lambrechts. (2010) Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy. Heredity 105:1, pages 152-160.
Crossref
Crossref
O. Safronova & I. Morita. (2010) Transcriptome Remodeling in Hypoxic Inflammation. Journal of Dental Research 89:5, pages 430-444.
Crossref
Crossref
Patricia G. YanceyJohn BlakemoreLei DingDaping FanCheryl D. OvertonYoumin ZhangMacRae F. LintonSergio Fazio. (2010) Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation. Arteriosclerosis, Thrombosis, and Vascular Biology 30:4, pages 787-795.
Crossref
Crossref
Tomoko Suzuki, Cory Yamashita, Rachel L. Zemans, Natalie Briones, Annemie Van Linden & Gregory P. Downey. (2009) Leukocyte Elastase Induces Lung Epithelial Apoptosis via a PAR-1–, NF-κB–, and p53-Dependent Pathway. American Journal of Respiratory Cell and Molecular Biology 41:6, pages 742-755.
Crossref
Crossref
Sang-Heng Kok, Cheng-Chang Yeh, Mei-Ling Chen & Mark Yen-Ping Kuo. (2009) Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncology 45:12, pages 1067-1072.
Crossref
Crossref
Olga Safronova, Sireerat Pluemsampant, Ken-ichi Nakahama & Ikuo Morita. (2009) Regulation of chemokine gene expression by hypoxia via cooperative activation of NF-κB and histone deacetylase. The International Journal of Biochemistry & Cell Biology 41:11, pages 2270-2280.
Crossref
Crossref
Fraczek Joanna, Vinken Mathieu, Snykers Sarah, Deleu Sarah, Vanderkerken Karin, Vanhaecke Tamara & Rogiers Vera. (2009) Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology. Journal of Cellular and Molecular Medicine 13:9b, pages 2990-3005.
Crossref
Crossref
Ailsa J. Frew, Ricky W. Johnstone & Jessica E. Bolden. (2009) Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Letters 280:2, pages 125-133.
Crossref
Crossref
J. H. Lim, J.-W. Park, K. S. Choi, Y. B. Park & T. K. Kwon. (2008) Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC -independent mechanism in human malignant tumor cells. Carcinogenesis 30:5, pages 729-736.
Crossref
Crossref
Vladimir N. Ivanov, Hongning Zhou, Michael A. Partridge & Tom K. Hei. (2009) Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells. Cancer Research 69:8, pages 3510-3519.
Crossref
Crossref
Teralee R. Burton, David D. Eisenstat & Spencer B. Gibson. (2009) BNIP3 (Bcl-2 19 kDa Interacting Protein) Acts as Transcriptional Repressor of Apoptosis-Inducing Factor Expression Preventing Cell Death in Human Malignant Gliomas. The Journal of Neuroscience 29:13, pages 4189-4199.
Crossref
Crossref
J Du, X Liang, Y Liu, Z Qu, L Gao, L Han, S Liu, M Cui, Y Shi, Z Zhang, L Yu, L Cao, C Ma, L Zhang, Y Chen & W Sun. (2008) Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Cell Death & Differentiation 16:2, pages 219-229.
Crossref
Crossref
Mei-Chin Lu, Ying-Chi Du, Jiunn-Jye Chuu, Shiuh-Lin Hwang, Pao-Chuan Hsieh, Chih-Sheng Hung, Fang-Rong Chang & Yang-Chang Wu. (2008) Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. Archives of Toxicology 83:2, pages 121-129.
Crossref
Crossref
Yue JiangBojan CukicDonald A. AdjerohHeath D. SkinnerJie LinQingxi J. ShenBing-Hua Jiang. (2009) An Algorithm for Identifying Novel Targets of Transcription Factor Families: Application to Hypoxia-inducible Factor 1 Targets. Cancer Informatics 7, pages CIN.S1054.
Crossref
Crossref
Monzur Rahman, Janet G. Pumphrey & Stanley Lipkowitz. 2009.
43
73
.
Anita C. Bellail, Patrick Mulligan & Chunhai Hao. 2009. CNS Cancer. CNS Cancer
977
1009
.
Wei Zou, Ping Yue, Fadlo R. Khuri & Shi-Yong Sun. (2008) Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation. Cancer Research 68:18, pages 7484-7492.
Crossref
Crossref
Jin H. Song, Karthikeyan Kandasamy & Andrew S. Kraft. (2008) ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis. Journal of Biological Chemistry 283:36, pages 25003-25013.
Crossref
Crossref
Ailsa J. FrewRalph K. LindemannBen P. MartinChristopher J. P. ClarkeJanelle SharkeyDesiree A. AnthonyKellie-Marie BanksNicole M. HaynesPradnya GangatirkarKym StanleyJessica E. BoldenKazuyoshi Takeda, Hideo Yagita, J. Paul Secrist, Mark J. SmythRicky W. Johnstone. (2008) Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist. Proceedings of the National Academy of Sciences 105:32, pages 11317-11322.
Crossref
Crossref
Y-J Jeon, I K Kim, S-H Hong, H Nan, H-J Kim, H-J Lee, E S Masuda, O Meyuhas, B-H Oh & Y-K Jung. (2008) Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene 27:31, pages 4344-4352.
Crossref
Crossref
Jun-Jie Chen, Chia-Wei Chou, Yu-Fan Chang & Ching-Chow Chen. (2008) Proteasome Inhibitors Enhance TRAIL-Induced Apoptosis through the Intronic Regulation of DR5: Involvement of NF-κB and Reactive Oxygen Species-Mediated p53 Activation. The Journal of Immunology 180:12, pages 8030-8039.
Crossref
Crossref
Ganchimeg Ishdorj, Bonnie A. Graham, Xiaojie Hu, Jing Chen, James B. Johnston, Xianjun Fang & Spencer B. Gibson. (2008) Lysophosphatidic Acid Protects Cancer Cells from Histone Deacetylase (HDAC) Inhibitor-induced Apoptosis through Activation of HDAC. Journal of Biological Chemistry 283:24, pages 16818-16829.
Crossref
Crossref
Francisco José Mendoza, Ganchimeg Ishdorj, Xiaojie Hu & Spencer B. Gibson. (2008) Death receptor-4 (DR4) expression is regulated by transcription factor NF-κB in response to etoposide treatment. Apoptosis 13:6, pages 756-770.
Crossref
Crossref
Karthikeyan Kandasamy & Andrew S. Kraft. (2008) Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3′-untranslated region. Molecular Cancer Therapeutics 7:5, pages 1091-1100.
Crossref
Crossref
Guang-Hui Liu, Jing Qu & Xun Shen. (2008) NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783:5, pages 713-727.
Crossref
Crossref
Cheol Park, Cheng-Yun Jin, Byung-Tae Choi, Won-Ho Lee & Yung-Hyun Choi. (2008) Induction of Apoptosis by HDAC Inhibitor Trichostatin A through Activation of Caspases and NF-κB in Human Prostate Epithelial Cells.. Journal of Life Science 18:3, pages 336-343.
Crossref
Crossref
Min Lu, Lijuan Xia, Huiming Hua & Yongkui Jing. (2008) Acetyl-Keto-β-Boswellic Acid Induces Apoptosis through a Death Receptor 5–Mediated Pathway in Prostate Cancer Cells. Cancer Research 68:4, pages 1180-1186.
Crossref
Crossref
Weiping Yu, Sook-Kyung Park, Li Jia, Richa Tiwary, Wenjun W. Scott, Jing Li, Pei Wang, Marla Simmons-Menchaca, Bob G. Sanders & Kimberly Kline. (2008) RRR-γ-tocopherol induces human breast cancer cells to undergo apoptosis via death receptor 5 (DR5)-mediated apoptotic signaling. Cancer Letters 259:2, pages 165-176.
Crossref
Crossref
Roya Khosravi-Far & Eileen WhiteSharmila Shankar & Rakesh K. Srivastava. 2008. Programmed Cell Death in Cancer Progression and Therapy. Programmed Cell Death in Cancer Progression and Therapy
261
298
.
Roya Khosravi-Far & Eileen WhiteKageaki Kuribayashi & Wafik S. El-Deiry. 2008. Programmed Cell Death in Cancer Progression and Therapy. Programmed Cell Death in Cancer Progression and Therapy
201
221
.
P. M. Chumakov. (2007) Versatile functions of p53 protein in multicellular organisms. Biochemistry (Moscow) 72:13, pages 1399-1421.
Crossref
Crossref
Xiu-Xian Wu, Xing-Hua Jin, Yu Zeng, Ahmed Mamdouh Abd El Hamed & Yoshiyuki Kakehi. (2007) Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression. Cancer Science 98:12, pages 1969-1976.
Crossref
Crossref
Shuzhen Chen, Xiangguo Liu, Ping Yue, Axel H. Schönthal, Fadlo R. Khuri & Shi-Yong Sun. (2007) CCAAT/Enhancer Binding Protein Homologous Protein-Dependent Death Receptor 5 Induction and Ubiquitin/Proteasome-Mediated Cellular FLICE-Inhibitory Protein Down-Regulation Contribute to Enhancement of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Dimethyl-Celecoxib in Human Non–Small-Cell Lung Cancer Cells. Molecular Pharmacology 72:5, pages 1269-1279.
Crossref
Crossref
Hisako Higashitsuji, Hiroaki Higashitsuji, Tomoko Masuda, Yu Liu, Katsuhiko Itoh & Jun Fujita. (2007) Enhanced Deacetylation of p53 by the Anti-apoptotic Protein HSCO in Association with Histone Deacetylase 1. Journal of Biological Chemistry 282:18, pages 13716-13725.
Crossref
Crossref
Nina Ritter, Eva Mussig, Thorsten Steinberg, Annette Kohl, Gerda Komposch & Pascal Tomakidi. (2007) Elevated expression of genes assigned to NF-κB and apoptotic pathways in human periodontal ligament fibroblasts following mechanical stretch. Cell and Tissue Research 328:3, pages 537-548.
Crossref
Crossref
Stavroula Baritaki, Sara Huerta-Yepez, Toshiyuki Sakai, Demetrios A. Spandidos & Benjamin Bonavida. (2007) Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. Molecular Cancer Therapeutics 6:4, pages 1387-1399.
Crossref
Crossref
Neil D. Perkins. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nature Reviews Molecular Cell Biology 8:1, pages 49-62.
Crossref
Crossref
M. Stacey Ricci & Wafik S. El-Deiry. 2007. Apoptosis, Senescence, and Cancer. Apoptosis, Senescence, and Cancer
31
54
.
Sharmila Shankar & Rakesh K. Srivastava. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
335
361
.
Sharmila Shankar & Rakesh K. Srivastava. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
219
261
.
Karen H. Vousden. (2006) Outcomes of p53 activation - spoilt for choice. Journal of Cell Science 119:24, pages 5015-5020.
Crossref
Crossref
M J Parsons & P M Vertino. (2006) Dual role of TMS1/ASC in death receptor signaling. Oncogene 25:52, pages 6948-6958.
Crossref
Crossref
Katie Schumm, Sonia Rocha, Jorge Caamano & Neil D Perkins. (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. The EMBO Journal 25:20, pages 4820-4832.
Crossref
Crossref
Senthil K. Radhakrishnan & Sitharthan Kamalakaran. (2006) Pro-apoptotic role of NF-κB: Implications for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1766:1, pages 53-62.
Crossref
Crossref
Rayleen V. BOWMAN, Ian A. YANG, Annalese B.T. SEMMLER & Kwun M. FONG. (2006) Epigenetics of lung cancer. Respirology 11:4, pages 355-365.
Crossref
Crossref
A M Martelli, M Nyåkern, G Tabellini, R Bortul, P L Tazzari, C Evangelisti & L Cocco. (2006) Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20:6, pages 911-928.
Crossref
Crossref
M. Stacey Ricci & Wei-Xing Zong. (2006) Chemotherapeutic Approaches for Targeting Cell Death Pathways. The Oncologist 11:4, pages 342-357.
Crossref
Crossref
Christine B. Yoo & Peter A. Jones. (2006) Epigenetic therapy of cancer: past, present and future. Nature Reviews Drug Discovery 5:1, pages 37-50.
Crossref
Crossref
Senthil K. Radhakrishnan & Sitharthan Kamalakaran. (2006) Time to harness the pro-apoptotic property of NFκB?. Nature Reviews Cancer 6:1, pages 90-90.
Crossref
Crossref